Clinical pharmacological trial of guanazole
Yakar, D.; Holland, J.F.; Ellison, R.R.; Freeman, A.
Cancer Research 33(5): 972-975
1973
ISSN/ISBN: 0008-5472 PMID: 4512954 Document Number: 64212
Document emailed within 1 workday
Related Documents
Kris, M.G.; Kinahan, J.J.; Gralla, R.J.; Fanucchi, M.P.; Wertheim, M.S.; O'Connell, J.P.; Marks, L.D.; Williams, L.; Farag, F.; Young, C.W. 1988: Phase i trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced cancer Cancer Research 48(19): 5573-5579Young, C.W.; Fanucchi, M.P.; Declan Walsh, T.; Baltzer, L.; Yaldaei, S.; Stevens, Y.W.; Gordon, C.; Tong, W.; Rifkind, R.A.; Marks, P.A. 1988: Phase i trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals Cancer Research 48(24 Part 1): 7304-7309
Spinner, D.; Walter, J.; Vazquez-Gragg, M.; Bloise, T.; Stafford-Smith, M.; Faulkner, E.; Taekman, J. 2011: Php74 Clinical Trial Learning Curves Affect Outcomes Measurement, Patient Safety and Trial Success: Contributing Factors and a Potential Solution in Clinical Trial Simulation Value in Health 14(3): A24-A25
Mbuagbaw, L.; Thabane, L.; Ongolo-Zogo, P.; Lang, T. 2011: The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial Trials 12: 145
Brockman, R.W.; Shaddix, S.; Laster, W.R.; Schabel, F.M. 1970: Inhibition of ribonucleotide reductase, DNA synthesis, and L1210 leukemia by guanazole Cancer Research 30(9): 2358-2368
Musa, M.N.; Lower, G.M.; Welling, P.G.; Johnson, B.M.; Kaiman, B.D.; Bryan, G.T. 1974: Absorption, tissue distribution, and excretion of the anti-neoplastic agent guanazole in the rat Research Communications in Chemical Pathology and Pharmacology 7(3): 497-512
Galler, A.S.; Bauer, T.L. 2009: A randomised phase II trial of preoperative chemotherapy of cisplatindocetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204) Yearbook of Oncology 2009: 194-195
Hu, D.; Xu, Z. 1997: Multicenter clinical trial of thrombolytic therapy in 1,406 patients with acute myocardial infarction. Collaborative Group of Clinical Trial for Urokinase Therapy Chinese Medical Journal 110(11): 839-842
Von Baeyer, H.; Hopfenmüller, W.; Riedel, E.; Affeld, K. 2003: Atherosclerosis: current concepts of pathophysiology and pharmacological intervention based on trial outcomes Clinical Nephrology 60(Suppl 1): S31-S48
Ndebele, P.M.; Wassenaar, D.; Munalula, E.; Masiye, F. 2012: Improving understanding of clinical trial procedures among low literacy populations: an intervention within a microbicide trial in Malawi Bmc Medical Ethics 13: 29
Evans, S.; Pocock, S. 2001: Societal responsibilities of clinical trial sponsors. Lack of commercial pay off is not a legitimate reason for stopping a trial Bmj 322(7286): 569-570
May, B.; Helmstaedt, D. 1975: Liver disease in drug addicts: clinical course-toxicological and clinical pharmacological aspects International Journal of Clinical Pharmacology and Biopharmacy 12(1-2): 50-56
Katayose, Y.; Yamamoto, K.; Nakagawal, K.; Takemura, S.; Takahashi, M.; Nakamura, R.; Shimamura, H.; Rikiyama, T.; Egawa, S.; Yoshda, H.; Motoi, F.; Naitoh, T.; Unno, M. 2015: Feasibility Assessment of Modified FOLFOX-6 as adjuvant treatment after resection of liver metastases from colorectal cancer: analyses of a multicenter phase II clinical trial (Miyagi-HBPCOG Trial-001) Hepato-Gastroenterology 62(138): 303-308
Overduin, L.M. 1992: Clinical trial on sustained-release phenytoin. Preliminary results of the open, non-controlled study. the Phenytoin Trial Group on Canine Epilepsy Tijdschrift Voor Diergeneeskunde 117(Suppl 1): 27s-28s
Alves, J.Guilherme.B.; de Araújo, C.Adriane.Fonseca.Leal.; Pontes, I.E.A.; Guimarães, Aélica.C.; Ray, J.G. 2014: The BRAzil MAGnesium (BRAMAG) trial: a randomized clinical trial of oral magnesium supplementation in pregnancy for the prevention of preterm birth and perinatal and maternal morbidity Bmc Pregnancy and Childbirth 14: 222
Bertsche, T.; Schulz, M. 2004: Melatonin. a clinical-pharmacological assessment Medizinische Monatsschrift für Pharmazeuten 27(2): 39-48
Tancrède, C.; Betourné, C. 1974: Bacteriological, pharmacological and clinical study of cephazolin La Nouvelle Presse Medicale 3: 34-37
Kovalenko, A.N. 1986: Clinical and pharmacological aspects of atherosclerosis in middle and old age Fel'dsher i Akusherka 51(11): 32-37
Storstein, O. 1971: Clinical-pharmacological evaluation of digitalis therapy Nordisk Medicin 85(13): 409-410
Mashkovskiĭ, M.D.; Iuzhakov, S.D.; Absava, G.I.; Erokhina, L.G.; Lebedeva, N.V. 1984: Pharmacological properties and clinical use of xanthinol nicotinate Klinicheskaia Meditsina 62(11): 30-34